Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of the American Geriatrics Society|October 2, 2019
When Women Rise, We All Rise: American Geriatrics Society Position Statement on Achieving Gender Equity in GeriatricsRebecca Boxer, Mary Norman, Peter Abadir, et al.Deutsches Arzteblatt International|January 25, 2024
Telephone Health Coaching and Remote Exercise Monitoring (TeGeCoach) in Peripheral Arterial Occlusive Disease—a Randomized Controlled TrialFarhad Rezvani, Dirk Heider, Hans-Helmut König, et al.Journal of the American Society of Nephrology : JASN|August 23, 2014
A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGSGentzon Hall, Rasheed A Gbadegesin, Peter Lavin, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 10, 2023
The effect of telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach) on health care cost and utilization: results of a randomized controlled trialDirk Heider, Farhad Rezvani, Herbert Matschinger, et al.Research Square|April 1, 2024
Induction of complementary immunogenic necroptosis and apoptosis cell death pathways inhibits cancer metastasis and relapseChristopher Egbulefu, Kvar Black, Xinming Su, et al.Oncoimmunology|September 14, 2016
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopRoch Houot, Philippe Gaulard, Robert Schreiber, et al.Communications Biology|January 19, 2026
Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathwaysChristopher Egbulefu, Kvar Black, Xinming Su, et al.Nature Genetics|May 10, 2016
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomasJoshua D Campbell, Anton Alexandrov, Jaegil Kim, et al.Biorxiv : the Preprint Server for Biology|January 7, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo A Ratsimandresy, Emma Doran, Hart S Dengler, et al.Pageof 6